Biotechnology

Waypoint Bio Secures $14.5M Seed Funding to Revolutionize Cell Therapy for Solid Tumors

July 3, 2024

2seventy bio Completes Asset Purchase Agreement with Novo Nordisk

July 2, 2024

Weave Bio Launches AutoIND and Secures $10M Seed Funding

June 3, 2024

Entact Bio Appoints Michael Gutch, Ph.D., as Chief Operating Officer

May 30, 2024

Vir Biotechnology Appoints Mark D. Eisner as Executive Vice President and Chief Medical Officer

May 30, 2024

Merck to Acquire Eyebiotech Limited for $3 Billion

May 30, 2024

Captivate Bio Expands with NEST Scientific USA

May 7, 2024

Asher Bio Secures $55M in Series C Funding for Cancer Therapy

April 18, 2024

Peter Carbone Named Chief Quality Officer at KBI Biopharma

April 2, 2024

#25 – Jay Srinivasan, CEO of Truvian

November 29, 2023